.Attributes Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint asks for incorporation of people with MASLD and also dimension of liver end results in cardio-- kidney-- metabolic trials, when records propose mechanistically probable perks as well as medical safety-- and also lays out factors to consider for test layout and also regulative commendation.